Advertisement
Journal Home
Search for

Volume 29, Issue 5, Pages 524-532 (September 2009)


View previous. 13 of 15 View next.

Economic Evaluation of Dialysis Therapies

Scott Klarenbach, MD, MScCorresponding Author Informationemail address, Braden Manns, MD, MSc§

Summary 

The prevalence of end-stage renal disease continues to increase globally, and most patients are treated with dialysis. Despite technological advances in dialysis care, the relatively high costs of providing dialysis have not decreased substantially over the past 4 decades. These 2 factors are a significant concern in this era of fiscal restraint and finite health care budgets. Economic evaluation of dialysis treatment consistently has shown that home-based hemodialysis and peritoneal dialysis are less costly than in-center hemodialysis. Although only a portion of patients may be eligible for this therapy, current use in Canada and the United States suggests that significantly more patients could be treated with these therapies, which would result in significant cost savings without compromising patient outcomes. There is some evidence to suggest that the modality of home nocturnal dialysis may offer improvements in clinical outcomes including quality of life, but further study of the cost effectiveness of this modality is required.

 Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada

 Institute of Health Economics, Edmonton, Alberta, Canada

 Department of Medicine, Division of Nephrology, University of Calgary, Calgary, Canada

§ Department of Community Health Sciences, University of Calgary, Calgary, Canada

Corresponding Author InformationAddress reprint requests to Scott Klarenbach, MD, MSc, Department of Medicine, Division of Nephrology, University of Alberta, 11-107 Clinical Sciences Building, 8440-112 St, Edmonton, Alberta, T6G 2G3 Canada

 Supported by a Scholarship Award from the Kidney Foundation of Canada, and a Population Health Investigator Award from the Alberta Heritage Foundation for Medical Research (S.K.); and supported by a Canadian Institutes of Health Research New Investigator Award (B.M.).

PII: S0270-9295(09)00104-1

doi:10.1016/j.semnephrol.2009.06.009


View previous. 13 of 15 View next.

Advertisement